Leukemia Research
Volume 27, Issue 9 , Pages 859-863 , September 2003

Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis

  • Traci E. Battle

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA
    • Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  • ,
  • Hugo Castro-Malaspina

      Affiliations

    • Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  • ,
  • John G. Gribben

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA
    • Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  • ,
  • David A. Frank

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA
    • Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-632-4714; fax: +1-617-632-6356.

Received 3 October 2002 ,Accepted 20 December 2002.

References 

  1. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, et al.  Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. 1997;94:861–866
  2. Frank DA, Mahajan S, Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain STAT1 and STAT3 constitutively phosphorylated on serine residues. J. Clin. Invest. 1997;100:3140–3148
  3. Chung JY, Huang C, Meng X, Dong Z, Yang CS. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure–activity relationship and mechanisms involved. Cancer Res. 1999;59:4610–4617
  4. Yang GY, Chen L, Lee MJ, Landau JM. Inhibition of growth and induction of apoptosis in human cancer cells by tea polyphenols. Carcinogenesis. 1998;19:611–616
  5. Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene. 2000;19:2496–2504
  6. Battle TE, Frank DA. The role of STATs in apoptosis. Curr. Mol. Med. 2002;2:381–392
  7. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nature Med. 1999;5:444–447
  8. Sun M, Wang G, Paciga JE, Feldman RI, Yuan Z-Q, Ma X-L, et al.  AKT1/PKBa kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 2001;159:431–437
  9. Ballif BA, Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Diff. 2001;12:397–408
  10. Ribera JM, Vinolas N, Urbano-Ipizua A, Gallart T, Montserrat E, Rozman C. “Spontaneous” complete remissions in chronic lymphocytic leukemia: report of three cases and review of the literature. Blood Cells. 1987;12:471–479
  11. Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood. 2000;96:2917–2924
  12. Collins RHJ, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, et al.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 1997;15:433–444
  13. Berchem GJ, Bosseler M, Mine N, Avalosse B. Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2. Anticancer Res. 1999;19:535–540
  14. Kolfschoten GM, Hulscher TM, Duyndam MC, Pinedo HM, Boven E. Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel. Biochem. Pharmacol. 2002;63:733–743

PII: S0145-2126(03)00009-2

doi: 10.1016/S0145-2126(03)00009-2

Leukemia Research
Volume 27, Issue 9 , Pages 859-863 , September 2003